Medeyra Shape (Subq)
£18.00
Medeyra Shape is the highest-density filler within the Medeyra range, designed for deep subcutaneous applications, facial volumisation and structural contouring. With a G-prime of 270–290 Pa, Shape provides a firmer, more supportive gel profile than Medeyra Fine and Medeyra Deep
Out of stock
Medeyra Shape (Sub-Q) Dermal Filler
Medeyra Shape is the highest-density filler within the Medeyra range, designed for deep subcutaneous applications, facial volumisation and structural contouring. With a G-prime of 270–290 Pa, Shape provides a firmer, more supportive gel profile than Medeyra Fine and Medeyra Deep, making it particularly suited to areas where volume, projection and definition are required.
Formulated with 24 mg/mL cross-linked hyaluronic acid and 3 mg/mL lidocaine, Medeyra Shape is designed to provide a balance of cohesivity, elasticity and plasticity while integrating into the treated area. The formulation uses M.A.R.T. (Molecular Adaptive Reinforcement Technology) and is supplied as a 1.1 mL pre-filled syringe.
Key Benefits of Medeyra Shape
- High-density hyaluronic acid dermal filler
- 24 mg/mL cross-linked hyaluronic acid
- 3 mg/mL lidocaine for increased treatment comfort
- High G-prime of 270–290 Pa
- Designed for deep subcutaneous placement
- Suitable for facial volume restoration and structural contouring
- Designed for pronounced wrinkles, folds and volume loss
- Suitable for defining facial contours and restoring projection
- Provides a firmer gel profile than Medeyra Fine and Deep
- Designed for long-lasting results of approximately 12–18 months, depending on individual factors and treatment area.
Recommended Treatment Areas
Medeyra Shape is designed for professional aesthetic applications where deeper volume restoration and structural support are required, including:
- Cheeks and cheekbones
- Chin enhancement
- Jawline and facial contouring
- Mid and lower face volumisation
- Deep facial folds and wrinkles
- Lip contouring and volume enhancement
- Restoration of age-related facial volume loss
- Non-surgical nose contouring where clinically appropriate
Its high-density profile makes it particularly suitable for practitioners seeking a filler capable of providing volume, projection and definition in deeper treatment planes.
Product Specifications
| Specification | Details |
|---|---|
| Product | Medeyra Shape |
| Product Type | Cross-Linked Hyaluronic Acid Dermal Filler |
| Hyaluronic Acid | 24 mg/mL |
| Lidocaine | 3 mg/mL |
| G-Prime | 270–290 Pa |
| Volume | 1.1 mL × 1 syringe |
| Injection Level | Deep subcutaneous |
| Needle | 25G |
| Cannula | 23G × 40 mm |
| Technology | M.A.R.T. (Molecular Adaptive Reinforcement Technology) |
| Typical Duration | 12–18 months* |
| Shelf Life | 24 months from manufacture |
| Storage | 2–25°C, protected from direct sunlight and freezing |
| Manufacturer | BNC Global, South Korea |
The 2026 BNC Global catalogue lists Medeyra Shape at 270–290 Pa, with 24 mg/mL HA, 3 mg/mL lidocaine, a 1.1 mL syringe, 25G needle and 23G × 40 mm cannula.
Medeyra Shape vs Fine & Deep
Medeyra Shape completes the Medeyra range by providing the highest G-prime and deepest intended injection level:
| Product | G-Prime | Intended Level | Typical Duration |
|---|---|---|---|
| Medeyra Fine | 80–100 Pa | Intradermal | 6–12 months |
| Medeyra Deep | 140–160 Pa | Subdermal | 8–12 months |
| Medeyra Shape | 270–290 Pa | Deep subcutaneous | 12–18 months |
This graduated range allows practitioners to select a Medeyra formulation according to the required degree of softness, support, volume and structural definition.
Why Choose Medeyra Shape?
Medeyra Shape provides practitioners with a high-density HA filler for deep volumisation, facial remodelling and contour definition. Its higher G-prime offers increased structural support compared with the Fine and Deep formulations, while its lidocaine-containing formulation is designed to improve patient comfort during treatment.
For professional use only. Medeyra Shape should only be administered by an appropriately qualified and trained aesthetic practitioner in accordance with the manufacturer’s current instructions for use, applicable regulations and professional standards.
Treatment longevity varies according to individual patient characteristics, treatment area, injection technique and metabolic factors. Always refer to the current manufacturer documentation for the most up-to-date product specifications and indications.
| Title | Default Title |
|---|
Related products
